To examine the effects of aberrant expression ofclass H major histocompatibility complex (MHC) proteins on tolerance development, transgenic mice expressing the I-Al genes under control of the pancreatic elastase promoter were produced. Such transgenic mice express I-Ad exclusively on exocrine pancreas, without expression in thymus or by lymphocytes. No spontaneous development of autoimmune reactivity toward exocrine pancreas was found in transgeneexpressing mice of an H-2b background even though such mice could produce in vitro allogeneic responses against I-Ad. When T cells from nontransgenic H-2b mice as well as transgenic H-2b mice were activated in vitro by I-Ad allogeneic stimulator cells and transferred to transgenic mice, an intense, destructive lymphocytic infiltrate specific for exocrine pancreas developed. These findings suggest that aberrant class II MHC expression alone may not trigger autoimmune reactions. Rather, the unresponsiveness to allogeneic class II MHC may result from the inability of exocrine pancreas to initiate primary responses by T cells.
T-lymphocyte activation must be strictly regulated to allow appropriate immune responses toward pathogens but prevent responses directed against self antigens. Among the mechanisms that may contribute to the maintenance of T-cell unresponsiveness to self antigens are clonal deletion of autoreactive clones during maturation within the thymus (1) (2) (3) , controls at the level of T-cell activation by antigenpresenting cells (APCs) (4) , and, possibly, peripheral suppression by regulatory T cells. Recognition by the T cell of foreign antigen presented by major histocompatibility complex (MHC) molecules on the APC provides one necessary step for activation. Thus, T-cell responses may be influenced by the level and distribution of MHC expression on APCs and nonlymphoid tissues. Class II MHC molecules are normally expressed on macrophages and dendritic cells, B lymphocytes, thymic epithelium, and a few other nonlymphoid tissues under restricted circumstances. Observations of inappropriate expression of class II MHC in target tissues of certain autoimmune diseases led to the hypothesis that induction of inappropriate class II MHC expression may underlie autoimmunity (5, 6) . For example, expression of class II MHC in thyroid epithelium or pancreatic beta cells would result in presentation of tissue-restricted self antigens from these organs, leading to an immune response directed against these tissues.
Recently, this hypothesis was directly tested by using transgenic mice that express modified class I and class II MHC genes. Class I (7) and class 11 (8, 9) MHC gene expression was targeted to beta cells of pancreatic islets. The clinical diabetes that resulted in these transgenic mice appears to be independent of immune mechanisms (7, 10) and may reflect a nonspecific interference with insulin production or processing. In one of these systems, peripheral T cells and thymocytes developed tolerance to the I-E transgene expressed in islets (9) .
To address how tolerance may develop to antigens not encountered in the thymus, we developed a system in which unique extrathymic expression of a strong T-cell antigen, allogeneic class II MHC, is achieved by expressing the I-Ad genes under control of the rat pancreatic elastase promoter (PEL) in transgenic mice. This promoter element has been shown to direct appropriate tissue and developmental gene expression in transgenic mice (11 Embryo Microinjection. The constructs were mixed and microinjected into pronuclei of embryos derived from mating male C57BL/6 mice to female (BALB/cBy x C57BL/6)F1 mice. Three founder mice transgenic for PEL-Ad and PEL-A were produced. RNA from tissues was isolated as described (12) .
Histology. Immunohistochemical analysis was carried out on 8-,um-thick frozen sections that were fixed briefly in acetone before staining. Biotinylated monoclonal antibodies used were MKD-6 (anti-I-Ad), 1D9 (anti-I-Ab), and B8-24 (anti-Kb). Diaminobenzidine (Sigma) was used as a chromagen for avidin-peroxidase staining.
Antigen Presentation. The T-cell hybridoma 3D054.8 (provided by P. Marrack, National Jewish Hospital, Denver) specifically responsive to ovalbumin peptide fragment 323-339 (OVA) presented by I-Ad, but not by I-A , was used to assess antigen presentation by paraformaldehyde-fixed APCs or tissues. The release of interleukin 2 by the hybridoma was assessed by determining the ability of supernatants to stimulate growth of the CTLL cell line. OVA peptide (13) was synthesized with an Applied Biosystems model 430 peptide synthesizer as described (14) .
Mixed Lymphocyte Cultures. Mixed lymphocyte cultures used nylon wool-purified spleen cells or lymph node cells as responders and irradiated spleen cells or fixed pancreatic acinar cells as stimulators (15) . Cultures were in 5% C02/95% Abbreviations: MHC, major histocompatibility complex; PEL, pancreatic elastase promoter; OVA, ovalbumin peptide fragment 323- 
339.
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air at 370C for 3 days and were then pulsed with 0. PEL-Ad Transgene Expression Is Restricted to Exocrine Pancreas. To produce transgenic animals expressing the class II MHC I-Ad molecule on pancreatic acinar cells, we constructed hybrid genes joining the rat PEL to the genomic coding region of both the Ad and A% genes ( Fig. 1 ). These were microinjected together into one-cell zygotes. Lines were derived from founders EA7, EA10, and EA12. Lines EA7 and EA10 expressed mRNA from both a-and 8-chain constructs and produced complete I-Ad heterodimer, whereas line EA12 expressed only a-chain mRNA.
To determine the tissue distribution and amount of transgene expression, RNA from tissues was analyzed by using RNase protection (16) . The PEL-Aa probe protected a 120-bp fragment in RNA from transgenic pancreas but not from transgenic spleen or thymus (Fig. 1C ). The PEL-Ap probe protected a 90-bp fragment, again only in RNA from transgenic pancreas. RNA from pancreas, spleen, thymus, or other tissues of nontransgenic animals did not show either band. These data indicate that the transgene was transcribed from the elastase promoter and only in the pancreas of transgenic mice, as expected. Importantly, thymus and spleen were negative for expression of the PEL-Ad transgene, as determined by RNase protection. Furthermore, by immunohistochemistry with a specific anti-I-Ad monoclonal antibody MKD-6, we identified the expression of I-Ad protein to be restricted specifically to the acinar cells in the pancreas (Fig. 2) . The pancreatic islets and the thymus were negative for expression (Fig. 2) .
PEL-Ad Functions in Antigen Presentation. Pancreatic tissue from transgenic mice was effective in presenting the OVA peptide to the I-Ad-restricted hybridoma 3DO54.8 (Fig. 3) . Pancreas from nontransgenic mice of either H-2b or H-2d haplotype failed to elicit hybridoma responses to OVA peptide. Importantly, spleen from transgenic H-2b animals did not elicit an OVA peptide response from the hybridoma (Fig.  3 ), showing at a functional level that the transgene expression is restricted to the pancreas. These data indicate that the PEL-Ad constructs are transcribed into functional I-Ad protein, can function in peptide-antigen presentation, and maintain the specificity of natural I-Ad.
Tolerance and Reactivity to PEL-Ad. To ascertain whether I-Ad-bearing pancreas will undergo spontaneous alloreaction in vivo, pancreas from transgenic and nontransgenic mice of both H-26 and H-2bxd haplotypes were examined histologically (Fig. 4) H-2b mice primed against H-2d into H-2b transgenic mice expressing pancreatic I-Ad (Table 1) . This adoptive transfer resulted in extensive lymphocytic infiltration specific for the exocrine pancreas of transgenic mice (Fig. 4) against I-E. Here, we have shown that I-Ad-expressing exocrine pancreas has functional I-A complexes, but that this is not sufficient for priming an allogeneic response in vitro or in vivo. Most recently, I-E was expressed on acinar cells under the elastase promoter in transgenic mice (18) . Again, no anti-pancreatic autoimmune reaction developed when acinar-pancreatic I-E was expressed in mice without thymic I-E. Also, in vitro mixed lymphocyte responses toward Fig. 4 , sparing the islets, and producing loss of acinar cells.
I-E-bearing stimulators were reduced, although not completely. Thus exocrine, like endocrine, pancreas seems unable to prime T-cell responses. In the present study, we cannot distinguish whether in vivo unresponsiveness toward pancreatic I-Ad stems only from lack of T-cell priming or whether there is also a component of T-cell anergy.
Clonal deletion of autoreactive T cells in the thymus is now well established as one means of induction of tolerance to self antigens (1) (2) (3) . This and other recent reports (16, (18) (19) (20) suggest that additional mechanisms exist to maintain tolerance to self antigens that are not presented in the thymus to the developing T-cell repertoire. Whatever the mechanisms used, the present data argue that such "peripheral tolerance" mechanisms do not involve the physical deletion or irreversible inactivation of the autoreactive T cells. 
